ARCHIVES

In Brief: FDA Cool To Committee Review of INDs; New Commissioner Is Donald Kennedy, Of Stanford

This article is from The Cancer Letter archive.

Vol. 03 No. 10 | March 11, 1977

Download PDF Visit The Full Archive

Related Articles

NCI Exceeded Mandate In Study Of Legislators, Rep. Porter Says

August 11, 1995

In Brief: Cancer Program “Greatest Experiment And it Works,” ACS President tells Congress

June 25, 1976

Mason Asks For Better Technology Transfer In Cancer Prevention

October 30, 1992

Obama Signs Law Authorizing $126 Million Over 10 Years for Pediatric Research

April 11, 2014

ADT May Increase Risk Of Cardio Events In Prostate Cancer Patients

February 5, 2010

House-Senate Conference Agrees On $1 Billion For NCI, Increases For All NIH Organizations

August 3, 1979